Optical biosensor with enhanced activity retention for detection of halogenated organic compounds

• US 7,381,538 B2
• Filed: 06/01/2002
• Issued: 06/03/2008
• Est. Priority Date: 06/01/2001
• Status: Expired due to Term

• Current Assignee: Colorado State University Research Foundation
• Original Assignee: Colorado State University Research Foundation
• Inventors: Reardon, Kenneth F., Das, Neema
• Primary Examiner(s): Carlson; Karen Cochrane
• Assistant Examiner(s): ROOKE, AGNES BEATA
• Application Number:
  US10/478,822
• Publication Number:
  US 20040265811A1
• Time in Patent Office: 2,194 Days
• Field of Search: None
• US Class Current: 435/23
• CPC Class Codes: C12Q 1/002 Electrode membranes
• CPC Class Codes: C12Q 1/005 involving specific analytes or enzymes including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence
• CPC Class Codes: G01N 2021/7723 Swelling part, also for adsorption sensor, i.e. without chemical reaction
• CPC Class Codes: G01N 2021/7786 Fluorescence
• CPC Class Codes: G01N 21/7703 using reagent-clad optical fibres or optical waveguides using measurement of total internal reflection or attenuated total reflection G01N21/552; optical fibres or waveguides per se G02B
• CPC Class Codes: G01N 21/80 Indicating pH value

Abstract

A distal tip, and associated method of producing, of a biosensor ion sensing transducer for use in detecting an analyte comprising an halogenated organic compound in an environment such as soil or an aqueous environment. Features include: a biocomponent comprising at least one enzyme for carrying out a dehalogenation of the compound; the biocomponent is immobilized to a surface of the tip; a treatment of the biocomponent for maintaining a period of enzymatic efficacy; and the biocomponent stabilized by means preferably selected from the group consisting of crosslinking a surface of the immobilized biocomponent, crosslinking a polymer layer to the biocomponent, adding a gel-hardening agent to the biocomponent, adding a stabilizing agent to the biocomponent, and modifying a component of the immobilizing means. Immobilization can be carried out by: (a) entrapment within a hydrogel; (b) entrapment within a polymeric network; (c) (micro)encapsulation; (d) covalent-bonding; and (e) adsorption. The dehalogenase of the biocomponent may be selected from the group consisting of hydrolases, subclass EC 3.8, and lyases, subclass EC 4.5 as listed in Table 2A.

Claims

1. A distal tip of a biosensor ion sensing transducer for use in detecting an analyte comprising a halogenated organic compound, the tip comprising:

a biocomponent comprising at least one enzyme selected from the group consisting of hydrolases, subclass EC 3.8, and lyases, subclass EC 4.5, for carrying out a dehalogenation of the compound, said biocomponent immobilized to a surface of the tip by means selected from the group consisting of (a) entrapment within a hydrogel;

(b) entrapment within a polymeric network;

(c) encapsulation;

(d) covalent-bonding; and

(e) adsorption;

wherein said biocomponent has been treated to maintain a period of enzymatic efficacy; and

wherein said biocomponent is stabilized to said tip by means selected from the group consisting of crosslinking a surface of said immobilized biocomponent, crosslinking a polymer layer to said biocomponent, adding a gel-hardening agent to said biocomponent, adding a stabilizing agent to said biocomponent, and modifying a component used to immobilize said biocomponent to said surface of the tip.

2. The distal tip of claim 1, said immobilization means comprising entrapment within said hydrogel, wherein said hydrogel is selected from the group consisting of algal polysaccharides, gelatin, collagen, pectin, poly(carbamoyl) sulfonate, locust bean gum, and gellan.

3. The distal tip of claim 1, further comprising an ion-sensing transducer selected from the group consisting of a pH optode, a pH electrode, a field-effect transistor (FET), and a halide ion-selective electrode (ISE).

4. The distal tip of claim 1, said biocomponent stabilized to said tip by crosslinking the polymer layer, wherein said crosslinked polymer layer is selected from the group consisting of poly-L-lysine, polyethylenimine, polyacrylic acid, polyvinyl alcohol, polyacrylamide, and polyurethane.

5. The distal tip of claim 1 wherein said hydrolases, subclass EC 3.8, comprise the enzymes selected from the group consisting of:

alkyl-halide halidohydrolase,

2-haloacid halidohydrolase,

haloacetate halidohydrolase,

1-halo alkane halidohydrolase,

4-chlorobenzoate chlorohydrolase,

4-chlorobenzoyl CoA chlorohydrolase,

atrazine chlorohydrolase,

s-triazine hydrolase,

dichloroacetate halidohydrolase,

DL-2-haloacid dehalogenase,

1,3,4,6-tetrachloro-1,4-cyclohexadiene halidohydrolase,

cis-chloroacrylic acid dehalogenase, and

trans-3-chloroacrylic acid dehalogenase;

and said lyases, subclass EC 4.5, comprise the enzymes selected from the group consisting of;

DDT-dehydrochlorinase (DDT-ase),

3-chloro-D-alanine chloride-lyase (deaminating),

dichloromethane chloride-lyase (chloride-hydrolysing),

L-2-amino-4-chloropent-4-enoate chloride-lyase (deaminating),

3-chloro-L-alanine chloride-lyase (adding thioglycolate),

halohydrin hydrogen-halide-lyase A,

halohydrin hydrogen-halide-lyase B,

DDD dehydrochlorinase,

DDMS dehydrochlorinase,

gamma-hexachlorocyclohexane dehydrochlorinase, and

5-chloro-1,2,4-trihydroxybenzene dechlorinase.

6. The distal tip of claim 1, wherein said biocomponent is treated according to a treatment selected from the group consisting of applying an inhibitor of protein synthesis, adding a protease inhibitor, freeze drying, and dry heating.

7. The distal tip of claim 6, wherein the protein synthesis inhibitor is selected from the group of antibiotics consisting of chloramphenicol, aminoglycosides, tetracyclines, and macrolides.

8. The distal tip of claim 1, said biocomponent stabilized to said tip by crosslinking the surface of said immobilized biocomponent using a crosslinking agent, wherein the crosslinking agent comprises glutaraldehyde.

9. The distal tip of claim 1, wherein said biocomponent is selected from whole isolated cells, purified enzymes, and combinations thereof.

10. A distal tip of a biosensor ion sensing transducer for use in detecting an analyte comprising a halogenated organic compound, the tip comprising:

a biocomponent comprising at least one enzyme selected from the group consisting of hydrolases, subclass EC 3.8, and lyases, subclass EC 4.5, for carrying out a dehalogenation of the compound, said biocomponent immobilized to a surface of the tip by means selected from the group consisting of (a) entrapment within a hydrogel;

(b) entrapment within a polymeric network;

(c) encapsulation;

(d) covalent-bonding; and

(e) adsorption,

wherein said biocomponent is stabilized to said tip by means selected from the group consisting of crosslinking a surface of said immobilized biocomponent, crosslinking a polymer layer to said biocomponent, adding a gel-hardening agent to said biocomponent, adding a stabilizing agent to said biocomponent, and modifying a component used to immobilize said biocomponent to said surface of the tip.

11. The distal tip of claim 10, said immobilization means comprising entrapment within said hydrogel, wherein said hydrogel is selected from the group consisting of algal polysaccharides, gelatin, collagen, pectin, poly (carbamoyl) sulfonate, locust bean gum, and gellan.

12. The distal tip of claim 10, further comprising an ion-sensing transducer selected from the group consisting of a pH optode, a pH electrode, a field-effect transistor (FET), and a halide ion-selective electrode (ISE).

13. The distal tip of claim 10, said biocomponent stabilized to said tip by crosslinking the polymer layer, wherein said crosslinked polymer layer is selected from the group consisting of poly-L-lysine, polyethylenimine, polyacrylic acid, polyvinyl alcohol, polyacrylamide, and polyurethane.

14. The distal tip of claim 10 wherein said hydrolases, subclass EC 3.8, comprise the enzymes selected from the group consisting of:

alkyl-halide halidohydrolase,

2-haloacid halidohydrolase,

haloacetate halidohydrolase,

1-haloalkane halidohydrolase,

4-chlorobenzoate chlorohydrolase,

4-chlorobenzoyl CoA chlorohydrolase,

atrazine chlorohydrolase,

5-triazine hydrolase,

dichloroacetate halidohydrolase,

DL-2-haloacid dehalogenase,

1,3,4,6-tetrachloro-1,4-cyclohexadiene halidohydrolase,

cis-chloroacrylic acid dehalogenase, and

trans-3-chloroacrylic acid dehalogenase;

and said lyases, subclass EC 4.5, comprise the enzymes selected from the group consisting of;

DDT-dehydrochlorinase (DDT-ase),

3-chloro-D-alanine chloride-lyase (deaminating),

dichloromethane chloride-lyase (chloride-hydrolysing),

L-2-amino-4-chloropent-4-enoate chloride-lyase (deaminating),

3-chloro-L-alanine chloride-lyase (adding thioglycolate),

halohydrin hydrogen-halide-lyase A,

halohydrin hydrogen-halide-lyase B,

DDD dehydrochlorinase,

DDMS dehydrochlorinase,

gamma-hexachlorocyclohexane dehydrochlorinase, and

5-chloro-1,2,4-trihydroxybenzene dechlorinase.

15. The distal tip of claim 10, wherein said biocomponent is treated to maintain a period of enzymatic efficacy according to a treatment selected from the group consisting of applying an inhibitor of protein synthesis, adding a protease inhibitor, freeze drying, and dry heating.

16. The distal tip of claim 15, wherein the protein synthesis inhibitor is selected from the group of antibiotics consisting of chloramphenicol, aminoglycosides, tetracyclines, and macrolides.

17. The distal tip of claim 10, said biocomponent stabilized to said tip by crosslinking the surface of said immobilized biocomponent using a crosslinking agent, wherein the crosslinking agent comprises glutaraldehyde.

18. The distal tip of claim 10, wherein said biocomponent is selected from whole isolated cells, purified enzymes, and combinations thereof.